Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Capital Expenditures (2016 - 2025)

Proto Labs' Capital Expenditures history spans 15 years, with the latest figure at $8.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 869.88% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $14.8 million, up 61.87%, while the annual FY2025 figure was $14.8 million, 61.87% up from the prior year.
  • Capital Expenditures for Q4 2025 was $8.0 million at Proto Labs, up from $4.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $18.2 million in Q4 2023 and bottomed at $830000.0 in Q4 2024.
  • The 5-year median for Capital Expenditures is $3.7 million (2021), against an average of $5.4 million.
  • The largest annual shift saw Capital Expenditures tumbled 95.43% in 2024 before it surged 869.88% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $6.3 million in 2021, then fell by 15.69% to $5.3 million in 2022, then surged by 244.86% to $18.2 million in 2023, then crashed by 95.43% to $830000.0 in 2024, then soared by 869.88% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for PRLB's Capital Expenditures are $8.0 million (Q4 2025), $4.1 million (Q3 2025), and $1.5 million (Q2 2025).